dosage 5 amino 1mq 5-Amino-1MQ Chart: 50-150mg/Day Oral Protocol (2026) 5 amino 1mq dosage chart

Meets USP standards

Skin that maintains healthy collagen and elastin networks shows fewer wrinkles and less sagging than skin with degraded structural support

Based on the clinical evidence and the patient profiles where the compound appears most applicable, the following characteristics tend to describe good candidates for AOD 9604 evaluation when it is medically supervised: Patients with stubborn localized fat deposits that have not responded to diet and exercise, particularly visceral and lower abdominal fat Patients who cannot tolerate GLP-1 medications due to nausea, gastrointestinal side effects, or contraindications Active patients with reasonable baseline metabolic health who want a targeted lipolytic tool to complement their training and nutrition program Patients already on a peptide protocol who want to add a fat-targeting element to a GHK-Cu, NAD+, or sermorelin stack Patients who are not candidates for stimulant-based fat loss medications due to cardiovascular sensitivity, anxiety, or blood pressure concerns AOD 9604 is not appropriate as a standalone weight loss strategy for patients with significant obesity, insulin resistance, or metabolic syndrome

Fill out the form below and our team will reach out to answer your questions about the AOD-9604 program

Caloric Deficit: The Non-Negotiable Foundation AOD-9604 releases free fatty acids from adipocytes

It's not a furnace blast